57105-50-7,
N-(3-Indolylacetyl)-L-phenylalanine,
(S)-2-(2-(1H-indol-3-yl)acetamido)-3-phenylpropanoic acid,
Indole-3-acetylphenylalanine,
IAA-L-Phe,
Indoleacetyl phenylalanine,
UNII-7DQ9F5L55Y,
Indole-3-acetyl-L-phenylalanine,
7DQ9F5L55Y,
L-phenylalanine, N-(1H-indol-3-ylacetyl)-,
I-1600,
Indol acetyl phenylalanine,
Indol-3 acetyl phenylalanine,
Phenylalanine, N-(1H-indol-3-ylacetyl)-,
AC1LD8T3,
L-Phenylalanine, N-(2-(1H-indol-3-yl)acetyl)-,
SCHEMBL503091,
(2S)-2-[[2-(1H-indol-3-yl)acetyl]amino]-3-phenylpropanoic acid,
CTK3F8282,
DTXSID30205728,
ZINC389660,
ANW-57419,
CI-111,
MFCD00075336,
AKOS015889635,
AJ-20897,
AN-40005,
AS-15813,
CC-31418,
Q873,
N-(1H-Indol-3-ylacetyl)-L-phenylalanine,
AX8009025,
TC-146164,
TL8003676,
FT-0629183,
ST24035859,
N-(3-Indolylacetyl)-L-phenylalanine, AldrichCPR,
105I507,
C-19729,
L-Phenylalanine, N-(1H-indol-3-ylacetyl)- (9CI),
(2S)-2-[[2-(1H-indol-3-yl)acetyl]amino]-3-phenyl-propanoic acid,
N- -L-phenylalanine,
C19H18N2O3,
CID644227,
ACN-033492,
A13327,
(S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoicacid,
92519-27-2,